Documents show Jean-Yves Duclos’s staff did not respond to requests to meet, so a briefing with the Patented Medicine Prices Review Board did not happen during a public consultation the minister suggested suspending
, and his office declined to comment on the newly released documents when asked by The Globe and Mail.
On Nov. 17, Mr. Clark called Jean-Sébastien Bock, the minister’s senior director of policy, and was told by a receptionist that he was busy and would call back. Mr. Bock did not return the call, so Mr. Clark tried again several hours later. The receptionist asked Mr. Clark what the call was about, and when he said “the PMPRB guidelines,” the receptionist said Mr. Bock would not take the call.
The documents also show that Prof. Bourassa Forcier was the only board member who wanted to heed Mr. Duclos’ request to suspend the consultation. The rest of the board members disagreed, which ultimately led her to resign as acting chair. The e-mails say PMPRB staff members met with Health Canada officials seven times throughout the fall to discuss the new guidelines. In an April 7 e-mail, PMPRB policy director Tanya Potashnik wrote that “at no time” did Health Canada suggest making any changes, which is one reason why Mr. Duclos’ letter was so unexpected.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
In Victoria, services for drug users not keeping pace as toxic drug crisis deepensThe demand for supervised injection and inhalation, along with safer supply, continues to grow
Read more »
Province demands return of thousands of documents allegedly copied by former District of Saanich IT workerThe Attorney General has petitioned the courts to compel a former Saanich IT manager to return to the district documents or digital copies of documents containing personal information
Read more »
Conservative motion to condemn Liberals on safe drug supply fails in House - National | Globalnews.caIn a vote of 209 to 113 Monday, MPs defeated a motion presented by Poilievre.
Read more »
House of Commons rejects Conservative motion to drop safe supply drug programConservatives\u0027 were hoping to redirect money dedicated to taxpayer\u002Dfunded opioids to treatment and recovery programs.
Read more »
House of Commons rejects Conservative motion to drop safe supply drug programConservatives\u0027 were hoping to redirect money dedicated to taxpayer\u002Dfunded opioids to treatment and recovery programs.
Read more »
House of Commons rejects Conservative motion to drop safe supply drug programConservatives\u0027 were hoping to redirect money dedicated to taxpayer\u002Dfunded opioids to treatment and recovery programs.
Read more »